» Authors » Brian Berman

Brian Berman

Explore the profile of Brian Berman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 206
Citations 2776
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peeva E, Guttman-Yassky E, Yamaguchi Y, Berman B, Oemar B, Ramakrishna J, et al.
Drug Discov Today . 2025 Feb; 30(3):104317. PMID: 39986647
Evolving research landscapes warrant updates in drug development strategy. Collaborations between pharmaceutical industry and academic institutions are crucial for accelerating drug development, leveraging individual expertise in clinical trial conduct and...
2.
Negida A, Vohra H, Lageman S, Mukhopadhyay N, Berman B, Weintraub D, et al.
Res Sq . 2024 Nov; PMID: 39606488
Subtyping Parkinson's disease with mild cognitive impairment (PD-MCI) could improve clinical trial design and personalized treatments. Cholinergic nucleus 4 (Ch4) volume has been linked to cognitive impairment severity and future...
3.
Rosenberg L, Shoham Y, Berman B, Tyring S, Tharp M, Singer A
J Clin Med . 2024 Nov; 13(21). PMID: 39518762
Basal cell carcinoma (BCC), the most prevalent form of human cancer, is traditionally treated by surgical and alternative destructive or topical chemical means, each with its advantages, challenges, and drawbacks....
4.
Beylergil S, Mukunda K, Elkasaby M, Perlmutter J, Factor S, Baumer T, et al.
Dystonia . 2024 Nov; 3. PMID: 39512809
Background: Cervical dystonia (CD) is the most common form of focal dystonia encountered in the clinic. Approximately one-third of CD patients have co-existing tremor in the head and hands. Assessment...
5.
Burshtein J, Zakria D, Shah M, Berman B, Desai S, Farberg A, et al.
J Drugs Dermatol . 2024 Sep; 23(9):774-781. PMID: 39231082
Background: Cutaneous melanoma (CM) is associated with a higher mortality rate than most other skin cancers. The purpose of this expert consensus panel was to review the published literature on...
6.
Mady A, Nabil Y, Daoud A, Alnajjar A, Alsalloum T, Marwan M, et al.
CNS Neurosci Ther . 2024 Aug; 30(8):e14888. PMID: 39097909
Background: Many observational studies have examined the association between statins and the incidence of Parkinson's disease (PD) in high-risk populations. On the other hand, clinical trials as well as other...
7.
Berman B, Armstrong A, Lebwohl M, Grada A, Bhatia N, Patel V, et al.
JAAD Int . 2024 Jul; 16:192-198. PMID: 39040844
Background: Current assessments on topical treatment attributes in actinic keratosis (AK) do not evaluate safety, effectiveness, and satisfaction from both clinician and patient perspectives, creating an unmet need for more...
8.
McCormick E, Han H, Azim S, Whiting C, Bhamidipati N, Kiss A, et al.
J Am Acad Dermatol . 2024 Jul; 91(5):855-862. PMID: 39025264
Background: UV-A radiation contributes to photoaging/photocarcinogenesis by generating inflammation and oxidative damage. Current photoprotective strategies are limited by the availability/utilization of UV-A filters, highlighting an unmet need. Cannabidiol (CBD), having...
9.
Schlesinger T, Kircik L, Lebwohl M, Patel V, Berman B, Bhatia N, et al.
J Drugs Dermatol . 2024 May; 23(5):338-346. PMID: 38709702
Background: The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study evaluated patient- and clinician-reported outcomes (PRO; ClinRO) during 24 weeks of follow-up among adult patients with actinic keratosis (AK) on the...
10.
Dirr M, Ahmed A, Schlessinger D, Haq M, Shi V, Koza E, et al.
JAMA Dermatol . 2024 Apr; 160(6):658-666. PMID: 38656294
Importance: Inconsistent reporting of outcomes in clinical trials of rosacea is impeding and likely preventing accurate data pooling and meta-analyses. There is a need for standardization of outcomes assessed during...